Everest Medicines Unveils Breakthroughs in AI+mRNA Platform, Reinforces Global Leadership in Next-Gen mRNA Innovation
Syntheia Signs Definitive Agreement for Call Center Acquisition
Intellistake Technologies Corp. Announces Completion of Change of Business, Name Change and Ticker Symbol Change
CORRECTING and REPLACING Vouched Developing Integration in Epic Toolbox Under Construction for Remote Identity Verification
Wells Fargo Scandal Drove Borrowers to Fintech Lenders, UC Davis Study Suggests
Alport syndrome is a rare progressive hereditary glomerular kidney disease caused by variants in COL4A…
OREM, Utah, June 28, 2023 (GLOBE NEWSWIRE) — Reflect Scientific, Inc. (OTCQB: RSCF), a leading…
RVT-3101 demonstrated improved efficacy results from the induction to chronic period in the TUSCANY-2 Phase…
OREM, Utah, June 28, 2023 (GLOBE NEWSWIRE) — Reflect Scientific, Inc. (OTCQB: RSCF), a leading…
SAN DIEGO, June 28, 2023 (GLOBE NEWSWIRE) — Ambrx Biopharma Inc., or Ambrx (or the…
SAN DIEGO, June 28, 2023 (GLOBE NEWSWIRE) — Ambrx Biopharma Inc., or Ambrx (or the…
BOSTON, June 28, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development…
BOSTON, June 28, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development…
SAN DIEGO, June 28, 2023 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech…
Former Awardee and Artelo Employee, Professor Saoirse O’Sullivan will Present the 2023 Recipient with the…
SAN DIEGO, June 28, 2023 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech…
Former Awardee and Artelo Employee, Professor Saoirse O’Sullivan will Present the 2023 Recipient with the…
Primary Endpoint of Safety and Efficacy Endpoint Both Met with Clinical Activity and Increased Survival…
Primary Endpoint of Safety and Efficacy Endpoint Both Met with Clinical Activity and Increased Survival…
Company intends to submit 510(k) pre-market notification to the FDA NEW YORK, June 28, 2023…
Company intends to submit 510(k) pre-market notification to the FDA NEW YORK, June 28, 2023…
MINNEAPOLIS, June 28, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc . (Nasdaq: PBLA), a clinical stage…
MINNEAPOLIS, June 28, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc . (Nasdaq: PBLA), a clinical stage…
Dr. Zhong Zhong joins Ovid as Chief Scientific Officer (CSO) and Dr. Manoj Malhotra assumes…
Dr. Zhong Zhong joins Ovid as Chief Scientific Officer (CSO) and Dr. Manoj Malhotra assumes…